Finch Therapeutics Group, Inc. (FNCH)
NASDAQ: FNCH · IEX Real-Time Price · USD
2.600
-0.240 (-8.45%)
At close: Mar 28, 2024, 1:10 PM
2.850
+0.250 (9.62%)
After-hours: Mar 28, 2024, 7:53 PM EDT

Finch Therapeutics Group Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Net Income
-74.75-114.65-58.16-39.34-20.75
Depreciation & Amortization
4.188.532.30.790.48
Share-Based Compensation
1.937.844.163.10.61
Other Operating Activities
37.1423.43-15.444.122.35
Operating Cash Flow
-31.51-74.85-67.13-31.33-17.32
Capital Expenditures
1.33-2.18-15.92-2.63-0.97
Investing Cash Flow
1.33-2.18-15.92-2.63-0.97
Share Issuance / Repurchase
00.29121.80.060.15
Debt Issued / Paid
-16.1614.72-0.031.764.73
Other Financing Activities
--0.13-2.6689.6648.42
Financing Cash Flow
-16.1614.87119.1191.4853.3
Net Cash Flow
-46.33-62.1636.0657.5135.01
Free Cash Flow
-30.18-77.03-83.05-33.96-18.29
Free Cash Flow Margin
-28203.74%-8946.92%-448.17%-439.98%-180.16%
Free Cash Flow Per Share
-18.81-48.46-63.56-125.09-75.22
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).